Advanced Biomed Inc. (NASDAQ: ADVB)

Sector: Healthcare Industry: Diagnostics & Research CIK: 0001941029
Market Cap 7.61 Mn
P/B 2.53
P/E -2.25
P/S 0.00
ROIC (Qtr) -92.30
Div Yield % 0.00
Rev 1y % (Qtr) 0.00
Total Debt (Qtr) 30,869.00
Debt/Equity (Qtr) 0.01

About

Price action

Investment thesis

Bull case

  • Healthy cash reserves of 2.66M provide 95.10x coverage of short-term debt 27934, demonstrating strong liquidity position and minimal refinancing risk.
  • Strong tangible asset base of 6.24M provides 202.24x coverage of total debt 30869, indicating robust asset backing and low credit risk.
  • Cash reserves of 2.66M provide solid 13.91x coverage of other non-current liabilities 190959, indicating strong liquidity.
  • Cash reserves of 2.66M provide robust 0.87x coverage of current liabilities 3.04M, indicating strong short-term solvency.
  • Robust R&D investment of 964060 at 0.47x of SG&A 2.06M demonstrates strong commitment to innovation and future growth.

Bear case

  • Investment activities of (13443) provide weak support for R&D spending of 964060, which is -0.01x, suggesting potentially insufficient investment in innovation relative to other capital deployment.
  • Free cash flow of (6.42M) provides weak coverage of capital expenditures of 13443, with a -477.51 ratio suggesting additional external financing needs for growth initiatives.
  • Operating earnings of (3.38M) show weak coverage of depreciation charges of 289604, with a -11.67 ratio indicating high capital intensity and potential reinvestment needs.
  • Free cash flow of (6.42M) represents just -7.23x of debt issuance 887963, suggesting concerning reliance on leverage rather than internal cash generation for growth.
  • Retained earnings of (19.62M) provide limited buffer against comprehensive income items of 1.26M, which is -15.63x, indicating elevated exposure to market risks.

Peer comparison

Companies in the Diagnostics & Research
S.No. Ticker Company Market Cap P/E P/S Total Debt (Qtr)
1 TMO Thermo Fisher Scientific Inc. 234.48 Bn 35.69 5.36 35.68 Bn
2 DHR Danaher Corp /De/ 171.11 Bn 48.85 7.05 16.86 Bn
3 IDXX Idexx Laboratories Inc /De 57.62 Bn 56.08 13.83 1.09 Bn
4 IQV Iqvia Holdings Inc. 42.37 Bn 33.03 2.66 15.19 Bn
5 A Agilent Technologies, Inc. 42.16 Bn 32.36 6.07 3.35 Bn
6 NTRA Natera, Inc. 31.64 Bn -102.32 14.95 0.18 Bn
7 MTD Mettler Toledo International Inc/ 30.89 Bn 36.96 7.84 2.21 Bn
8 WAT Waters Corp /De/ 23.59 Bn 36.37 7.60 1.49 Bn

Industry comparisons

Current Valuation Value Ind Avg Percentile
EV to Assets EV to Assets 0.42 2.82
EV to Cash from Ops. EV/CFO -0.41 19.55
EV to Debt EV to Debt 84.37 54.87
EV to EBIT EV/EBIT -0.77 18.82
EV to EBITDA EV/EBITDA -0.95 4.36
EV to Free Cash Flow [EV/FCF] EV/FCF -0.41 17.63
EV to Market Cap EV to Market Cap 0.34 1.58
EV to Revenue EV to Revenue 0.00 5.06
Price to Book Value [P/B] P/B 2.53 1.35
Price to Earnings [P/E] P/E -2.25 18.88
Dividend Metrics Value Ind Avg Percentile
Dividend Coverage Ratio Dividend Coverage Ratio 0.00 -2.00
Dividend Payout Ratio % Div Payout % (Qtr) 0.00 2.86
Dividend per Basic Share Div per Share (Qtr) 0.00 0.19
FCF Dividend Payout Ratio % FCF Div Payout % (Qtr) 0.00 1.94
Interest Coverage Interest Coverage 0.00 -128.90
Growth Metrics Value Ind Avg Percentile
Capex Growth (1y) % Capex 1y % (Qtr) 85.71 -35.01
Cash and Equivalents Growth (1y) % Cash & Equiv 1y % (Qtr) 0.36 23.84
Dividend Growth (1y) % Dividend Growth (1y) % 0.00 0.25
EBIAT Growth (1y) % EBIAT 1y % (Qtr) -48.48 9.72
EBITDA Growth (1y) % EBITDA 1y % (Qtr) -23.83 -444.66
EBIT Growth (1y) % EBIT 1y % (Qtr) -48.48 8.29
EBT Growth (1y) % EBT 1y % (Qtr) -48.48 -6.03
EPS Growth (1y) % EPS 1y % (Qtr) -45.45 15.59
FCF Growth (1y) % FCF 1y % (Qtr) -293.58 56.57
Gross Profit Growth (1y) % Gross Profit Growth (1y) % 0.00 185.75
Liquidity Ratios Value Ind Avg Percentile
Asset Utilization Ratio Asset Util Ratio (Qtr) 0.00 0.57
Cash Payout Ratio Cash Payout (Qtr) 0.00 0.01
Cash Ratio Cash Ratio (Qtr) 0.87 1.23
Current Ratio Curr Ratio (Qtr) 1.92 2.70
Debt to Equity Ratio Debt/Equity (Qtr) 0.01 -0.84
Interest Cover Ratio Interest Cover Ratio 0.00 -128.90
Times Interest Earned Times Interest Earned 0.00 -128.90
Profitability Value Ind Avg Percentile
EBITDA Margin % EBITDA Margin % 0.00 -97.22
EBIT Margin % EBIT Margin % 0.00 -115.64
EBT Margin % EBT Margin % 0.00 -114.24
Gross Margin % Gross Margin % 0.00 44.76
Net Profit Margin % Net Profit Margin % 0.00 -113.12